We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPE icon
526
Hewlett Packard
HPE
$60.5B
$2.04M 0.01%
129,690
-9,738
-7% -$147K
TWTR
527
DELISTED
Twitter, Inc.
TWTR
$2.01M 0.01%
46,509
-113
-0.2% -$5.87K
LNG icon
528
Cheniere Energy
LNG
$54.5B
$2M 0.01%
19,722
+1,332
+7% +$139K
IEX icon
529
IDEX
IEX
$17.1B
$1.99M 0.01%
8,425
-27,414
-76% -$6.23M
VRSN icon
530
VeriSign
VRSN
$26B
$1.99M 0.01%
7,829
+769
+11% +$178K
MCK icon
531
McKesson
MCK
$106B
$1.98M 0.01%
7,969
-565
-7% -$124K
GNRC icon
532
Generac Holdings
GNRC
$11.7B
$1.97M 0.01%
5,586
– –
VRSK icon
533
Verisk Analytics
VRSK
$29B
$1.96M 0.01%
8,549
-555
-6% -$121K
TLYS icon
534
Tilly's
TLYS
$114M
$1.93M 0.01%
120,000
– –
TTWO icon
535
Take-Two Interactive
TTWO
$46.4B
$1.93M 0.01%
10,839
-279
-3% -$48.6K
CNP icon
536
CenterPoint Energy
CNP
$29B
$1.91M 0.01%
68,570
– –
K
537
DELISTED
Kellanova
K
$1.91M 0.01%
31,613
-4,872
-13% -$288K
OSPN icon
538
OneSpan
OSPN
$579M
– –
0
– –
SYRS
539
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.91M 0.01%
58,427
– –
ARE icon
540
Alexandria Real Estate Equities
ARE
$9.62B
$1.9M 0.01%
8,512
-611
-7% -$126K
KDP icon
541
Keurig Dr Pepper
KDP
$42.4B
$1.9M 0.01%
51,493
-3,445
-6% -$121K
CP icon
542
Canadian Pacific Kansas City
CP
$80.7B
$1.89M 0.01%
26,259
+4,056
+18% +$296K
FTV icon
543
Fortive
FTV
$18.7B
$1.89M 0.01%
32,786
-2,054
-6% -$116K
EPAM icon
544
EPAM Systems
EPAM
$5.49B
$1.88M 0.01%
2,817
+1,225
+77% +$788K
AKRO
545
DELISTED
Akero Therapeutics
AKRO
$1.88M 0.01%
88,876
-37,791
-30% -$838K
MTCH icon
546
Match Group
MTCH
$9.27B
$1.87M 0.01%
14,108
+728
+5% +$105K
BN icon
547
Brookfield
BN
$102B
$1.86M 0.01%
57,151
-12,512
-18% -$396K
VMC icon
548
Vulcan Materials
VMC
$37.7B
$1.84M 0.01%
8,861
-529
-6% -$102K
HUBS icon
549
HubSpot
HUBS
$12.7B
$1.84M 0.01%
2,788
-3,240
-54% -$2.45M
GWW icon
550
W.W. Grainger
GWW
$64.8B
$1.83M 0.01%
3,538
-3,765
-52% -$1.78M
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.